Skip to main navigation Skip to search Skip to main content

Cytotoxic action of low dose Ara-C. Investigations in a marrow grafted patient with relapse

  • J. Mittermuller
  • , H. J. Kolb
  • , H. H. Gerhartz
  • , W. Wilmanns
  • Ludwig-Maximilians-Universität München

Research output: Contribution to journalArticlepeer-review

1 Scopus citations

Abstract

A 35-year-old woman relapsing from acute myeloid leukemia (AML) after a bone marrow transplantation (BMT) achieved complete remission by low dose Ara-C treatment. Phosphoglucomutase 1 (PGM 1) isoenzyme analysis gave evidence for complete chimerism before relapse, whereas relapsing leukemia was autochtonous. Low dose Ara-C treatment cleared the marrow of leukemic blasts and reestablished normal in vitro growth patterns of myelopoiesis. Disappearance of autochthonous cells and regrowth of transplanted hematopoiesis was shown by PGM 1 isoenzyme analysis. Thus, low dose Ara-C exerted its action - at least in this patient - by cytotoxic mechanisms.

Original languageEnglish
Pages (from-to)168-171
Number of pages4
JournalOnkologie
Volume8
Issue number3
StatePublished - 1985
Externally publishedYes

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Fingerprint

Dive into the research topics of 'Cytotoxic action of low dose Ara-C. Investigations in a marrow grafted patient with relapse'. Together they form a unique fingerprint.

Cite this